Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases
Open Access
- 21 July 2017
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 106 (1) , 74-88
Abstract
This review evaluates the diagnostic efficacy of different morphological and functional imaging modalities (ultrasound [US], computed tomography [CT], magnetic resonance [MR] imaging, scintigraphy, and positron emission tomography [PET]) in detecting neuroendocrine liver metastases (NELM), assessing vascular and biliary involvement, and the presence of extrahepatic disease. MR imaging is superior for depicting NELM compared to US, CT, and somatostatin receptor scintigraphy. Diffusion-weighted MR imaging is more sensitive for detecting NELM than both T2-weighted and dynamic gadolinium-enhanced MR sequences, and should be systematically performed. Similarly, gadoxetic acid-enhanced MR imaging is more sensitive for detecting liver metastases than conventional extracellular gadolinium chelate-enhanced MR sequences. Its role in detecting NELM remains investigational but appears promising. Somatostatin receptor-targeted PET/CT is a highly effective approach in assessing the resectability of well-differentiated NELM due to very high specificity (and high sensitivity) and its ability to detect small volume extrahepatic disease; this molecular imaging modality is becoming increasingly available in and outside Europe after the recent approval of 6868-DOTATATE in the US. In addition, the information from multiphase, contrast-enhanced CT with 3D reconstruction - obtained concurrently with the information on somatostatin receptor expression of the metastases - is very helpful in planning the extent and type of resection of NELM.Keywords
This publication has 81 references indexed in Scilit:
- Systematic review of the use of pre-operative simulation and navigation for hepatectomy: current status and future perspectivesJournal of Hepato-Biliary-Pancreatic Sciences, 2015
- Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastasesBritish Journal of Surgery, 2012
- Diagnosis of colorectal hepatic metastases: Comparison of contrast‐enhanced CT, contrast‐enhanced US, superparamagnetic iron oxide‐enhanced MRI, and gadoxetic acid‐enhanced MRIJournal of Magnetic Resonance Imaging, 2011
- The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one centerJournal of Endocrinological Investigation, 2010
- Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic diseaseBritish Journal of Surgery, 2009
- Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDGCancer, 2008
- 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experienceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- MRI of carcinoid tumors: Spectrum of appearances in the gastrointestinal tract and liverJournal of Magnetic Resonance Imaging, 2001
- Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997